Therefore, since Flt3L has been identified as the primary differentiation factor for DCs [30,32], we expanded DCs by injection of Flt3L-transfected BL16 melanoma in TNFRp55-/- and WT mice to generate an experimentally useful amount of DCs. This evidence concerns the gene FLT3LG and melanoma.